4Moore M J,Goldstein D,Hamm J,et al.Erlotinib plusgemcitabine compared with gemcitabine alone in patientswith advanced pancreatic cancer:a phase III trial of theNational Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology . 2007
5Ishikawa O,Ohhigashi H,Sasaki Y,et al.Extended pancre-atectomy and liver perfusion chemotherapy for resectableadenocarcinoma of the pancreas. Digestion . 1990
6Splinter,T.A.W.,Obertop,H.,Kok,T.C.Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. J. Cancer Res. Clin. Oncol . 1989
7Matsui Y,Nakagawa A,Kamiyama Y,et al.Selec-tive thermocoagulation of unresectable pancreaticcancers by using radiofrequency capacitive heating. Pancreas . 2000
8Jemal A,Siegel R,Ward E,et al.Cancer statistics, 2007. CA A Cancer Journal for Clinicians . 2007
9Wagner M,Redaelli C,Lietz M,et al.Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. The British Journal of Surgery . 2004
10Burris HA,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology . 1997
5[1]Tsiotos GG, Farnell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving?World J Surg, 1999,23(9):913.
6[2]Yamamoto M, Ohashi O, Saitoh Y. Japan pancreatic cancer registry : current status. Pancreas, 1998, 16(3) : 238.
7[3]Osamu Ishikawa,Hiroaki Ohigashi,Yo Sasaki,et al. Practical grouping of positive lymph nodes in pancreatic heed cancer treated by an extended pancreatectomy. Surgery, 1997,121:244.
8[4]Wenger FA, Peter F, Zieren J, et al. Prognosis factors in carcioma of the head of the pancreas. Dig Surg, 2000, 17(1):29.
9[5]Benassai G, Mastrerilli M, Quarto G, et al. Survival after pancreaticoduedenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital, 2000,52(3) : 263.
